drugset / Trial / NCT01370681

A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject

NCT01370681 ↗

Phase 1 Completed 30 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

The objective of this study is to demonstrate the bioequivalence of CJ30001(fixed-dose combination tablet of HKB0701 and SLM0807) relative to HKB0701 and SLM0807 co-administered to healthy subjects.

Timeline

Start
2009-10
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CJ30001 Unknown — —
Subject HKB0701 Unknown — —
Subject SLM0807 Unknown — —

Indications